NextCure
NXTC
NXTC
92 hedge funds and large institutions have $180M invested in NextCure in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 33
44% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $3.08M
Holders
92
Holding in Top 10
1
Calls
$1.73M
Puts
$3.08M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$6.44M | |
| 3 | +$3.2M | |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$2.79M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$2.79M |
Top Sellers
| 1 | -$12M | |
| 2 | -$4.89M | |
| 3 | -$1.42M | |
| 4 |
Man Group
London,
United Kingdom
|
-$970K |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$761K |